Contact
 
News related to the Enterprise, its Stakeholders, and HIV Vaccine Research

Enterprise Announces First Timely Topics - November 2, 2012

The Global HIV Vaccine Enterprise will convene partners from around the world to address two priority issues in HIV vaccine research and development: HIV prevention trials in infants, and vaccine-induced sero-positivity.  Click here to read the full announcement. 

Progress and Challenges in The Search For An HIV Vaccine Highlighted as Researchers, Funders and Policy-Makers Gather For Aids Vaccine 2012 In Boston - September 6, 2012

Scientists from around the world will gather in Boston at AIDS Vaccine 2012 to present more than 400 new research studies updating global progress in the search for a safe and effective HIV vaccine.  The conference, hosted by the Global HI Vaccine Enterprise, Harvard Center for AIDS Research and the Ragon Institute, runs 09 - 12 September.  Read More.

 

Join us on 24 July for a Session the Role of HIV Vaccines at AIDS 2012 - July 24, 2012

Join us for an interactive session where we will review exciting developments that are opening new avenues in HIV vaccine science. The session features Margaret McCluskey of USAID, Mitchell Warren of AVAC, Nina Russell from the Gates Foundation, Bill Snow from the Enterprise and many others.  Visit, http://pag.aids2012.org/session.aspx?s=160 for more information.

Announcing Timely Topics in HIV Vaccines: Call for Proposals - July 16, 2012

The Enterprise launched Timely Topics in HIV Vaccines to analyze, address and respond to strategic issues in the field.  We are seeking proposals for hot topics that will help move the HIV vaccine endeavor forward.  For more information, visit http://www.vaccineenterprise.org/content/timely-topics-hiv-vaccines

Bloomberg Features P5 and its Efforts to Improve on RV144 Results - June 27, 2012

Bloomberg ran a piece on the Pox-Protein Public Private Partnership (P5) and their plans to improve on the RV144 Thai HIV vaccine trial results. Check it out, http://www.bloomberg.com/news/2012-06-26/shark-oil-for-aids-takes-cue-fr....

Public Health Agency of Canada - World AIDS Vaccine Day Statement - May 22, 2012

In its World AIDS Vaccine Day statement, the Public Health Agency of Canada noted that through the Canadian HIV Vaccine Intiative, five new research teams are dedicating their work to accelerating HIV vaccine R&D, which is helping to strengthen the links between Canadian and other researchers around the world.  

Vaccine is the Best Hope Against AIDS - AAVP, IAVI, UNAIDS Editorial - May 18, 2012

In an editorial published in the Mail & Guardian, Michel Sidibe, Chidi Nweneka and Margaret McGlynn wrote that despite the advances in the management of HIV, an effective vaccine to prevent HIV would save billions.  The full piece can be found here, http://mg.co.za/article/2012-05-18-vaccine-is-the-best-hope-against-aids.

Time for an HIV Vaccine - MHRP Statement - May 17, 2012

The U.S. Military HIV Research Program issued a statement by COL. Nelson Michael highlighting the Military's efforts to develop a globally effective HIV vaccine.  The statement is available here, http://www.hivresearch.org/news.php?NewsID=240&GlobalID=11

HIV Vaccine Awareness Day Worldwide Activities - May 15, 2012

Enterprise stakeholders are conducting activities/events all around the world to commemorate HIV Vaccine Awareness Day, 18 May.  Check out our comprehensive listing of activities going on this week, http://www.vaccineenterprise.org/content/HVAD2012.   We hope you will show your support and participate in one or many!

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account